Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-19-007033

SVP, Chief Medical Officer gave up 706 shares (to pay taxes)

  • SVP, Chief Medical Officer acquired 2,043 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Chondros Dimitrios · SVP, Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-06-01 Exercise or conversion : show line 1 in the form +2,043 40,618 D
2019-06-01 Shares withheld for taxes : show line 2 in the form −706 $14.75 $10,414 39,912 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Underlying Owned after D/I
2019-06-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −2,043 $0.00 2,043 4,084 D
Loading xslF345X03/edgar.xml…